Home / Health / Fecal Pill Poised to Conquer IBS Symptoms
Fecal Pill Poised to Conquer IBS Symptoms
26 Jan
Summary
- A fecal transplant pill may significantly reduce IBS symptoms.
- Two doses of the pill EBX-102-02 proved effective in a UK trial.
- The treatment aims to restore a healthy balance of gut bacteria.

A novel pill made from human faeces, identified as EBX-102-02, is emerging as a potential breakthrough for individuals suffering from Irritable Bowel Syndrome (IBS). This innovative treatment aims to restore a healthy balance within the gut microbiome, which plays a critical role in digestive health.
Recent findings from a UK clinical trial involving 122 IBS patients revealed that administering two doses of EBX-102-02 a week apart led to a significant reduction in severe symptoms. These symptoms commonly include diarrhoea, constipation, stomach cramps, and bloating.
Almost 60% of trial participants reported substantial symptom relief in the weeks and months following the treatment. A larger study is planned for later in 2026 to confirm these promising results. If successful, this drug could become available on the NHS within a few years.




